McKesson Corporation

MCK
Delayed Nyse - 02/14 10:04:22 pm
168.03USD
+0.07%
Prev.167.9100
Open167.0900
High168.5000
Low164.2500
Volume5 000 487
Financials
Sales 2020 228 B
EBIT 2020 3 786 M
Net income 2020 474 M
Debt 2020 4 732 M
Yield 2020 0,97%
P/E ratio 2020 64,4x
P/E ratio 2021 13,1x
EV / Sales2020 0,15x
EV / Sales2021 0,14x
Capitalization 29 755 M
Company
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (91%);
- distribution of medical and surgical products (3.5%);
-...
Sector :
Drug Retailers - NEC
Calendar :
2020-02-28 MCKESSON CORPORATION : Ex-dividend day for
Trading Rating :
Investor Rating :
Latest news
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Litigation -- 3rd Update
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Litigation -- 3rd Update
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Litigation -- 2nd Update
DJ
02/1421 States Reject $18 Billion Offer From Drug Wholesalers to Settle Opioid Litigation -- Update
DJ
02/10MCKESSON CORP : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
AQ
02/10MCKESSON : Launches Exchange Offer to Split-Off Its Interest in Change Healthcare
BU
02/04MCKESSON : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
02/04MCKESSON : Revenue Misses Expectations, Adjusted Earnings Beat
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishBullishBullish
Resistance185185177
Spread/Res.-9,2%-9,2%-5,1%
Spread/Supp.12%12%23%
Support151151137